Agenus to participate in february investor conferences

Lexington, mass., jan. 26, 2023 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, today announced that dr. garo armen, chairman and ceo, and dr. steven o'day, chief medical officer, will participate in the following upcoming investor conferences:
AGEN Ratings Summary
AGEN Quant Ranking